Technical Analysis for JNCE - Jounce Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 4.71 -3.29% -0.16
JNCE closed down 3.29 percent on Monday, May 20, 2019, on 74 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical JNCE trend table...

Date Alert Name Type % Chg
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -3.29%
Below Lower BB Weakness -3.29%

Older signals for JNCE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Biotechnology Life Sciences Biology Natural Sciences Immunology Immunotherapy Solid Tumors Immune System Monoclonal Antibodies
Is JNCE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.85
52 Week Low 2.66
Average Volume 212,464
200-Day Moving Average 5.4632
50-Day Moving Average 5.9778
20-Day Moving Average 5.5195
10-Day Moving Average 5.326
Average True Range 0.3802
ADX 22.95
+DI 12.4655
-DI 30.3125
Chandelier Exit (Long, 3 ATRs ) 4.8594
Chandelier Exit (Short, 3 ATRs ) 5.7106
Upper Bollinger Band 6.1982
Lower Bollinger Band 4.8408
Percent B (%b) -0.1
BandWidth 24.592807
MACD Line -0.2417
MACD Signal Line -0.1483
MACD Histogram -0.0935
Fundamentals Value
Market Cap 151.45 Million
Num Shares 32.2 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 157.00
Price-to-Sales 5.66
Price-to-Book 2.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.33
Resistance 3 (R3) 5.35 5.16 5.22
Resistance 2 (R2) 5.16 5.01 5.15 5.19
Resistance 1 (R1) 4.94 4.91 4.85 4.92 5.15
Pivot Point 4.75 4.75 4.71 4.74 4.75
Support 1 (S1) 4.53 4.60 4.44 4.51 4.27
Support 2 (S2) 4.34 4.50 4.33 4.23
Support 3 (S3) 4.12 4.34 4.20
Support 4 (S4) 4.10